Positive News SentimentPositive NewsNASDAQ:AIMD Ainos (AIMD) Stock Price, News & Analysis $0.50 -0.04 (-8.03%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock About Ainos Stock (NASDAQ:AIMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Ainos alerts:Sign Up Key Stats Today's Range$0.49▼$0.5550-Day Range$0.48▼$0.7552-Week Range$0.40▼$1.17Volume182,761 shsAverage Volume483,613 shsMarket Capitalization$10.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAinos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.Read More… Ainos Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks27th Percentile Overall ScoreAIMD MarketRank™: Ainos scored higher than 27% of companies evaluated by MarketBeat, and ranked 832nd out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Ainos. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Ainos is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Ainos is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAinos has a P/B Ratio of 0.10. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Ainos' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted57.10% of the float of Ainos has been sold short.Short Interest Ratio / Days to CoverAinos has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ainos has recently decreased by 10.38%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAinos does not currently pay a dividend.Dividend GrowthAinos does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted57.10% of the float of Ainos has been sold short.Short Interest Ratio / Days to CoverAinos has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Ainos has recently decreased by 10.38%, indicating that investor sentiment is improving significantly. News and Social Media3.8 / 5News SentimentN/A News SentimentAinos has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Ainos this week, compared to 0 articles on an average week.Search Interest3 people have searched for AIMD on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Ainos to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Ainos insiders have not sold or bought any company stock.Percentage Held by Insiders10.39% of the stock of Ainos is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Ainos' insider trading history. Receive AIMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ainos and its competitors with MarketBeat's FREE daily newsletter. Email Address AIMD Stock News HeadlinesAinos, Inc.: Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%May 29, 2025 | finanznachrichten.deAinos, Inc.: Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal ImmunotherapyMay 20, 2025 | finanznachrichten.deElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.June 13, 2025 | Banyan Hill Publishing (Ad)Ainos, Inc.: Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing RapidlyApril 24, 2025 | finanznachrichten.deAinos, Inc.: Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is ScalingApril 11, 2025 | finanznachrichten.deWater Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose’s Potential in Chip Manufacturing and MoreMarch 13, 2025 | finance.yahoo.comAinos, Inc.: Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor ManufacturingMarch 11, 2025 | finanznachrichten.deAinos and ASE Partner to Power AI Scent Digitization in Semiconductor ManufacturingMarch 11, 2025 | finance.yahoo.comSee More Headlines AIMD Stock Analysis - Frequently Asked Questions How have AIMD shares performed this year? Ainos' stock was trading at $0.4560 at the beginning of 2025. Since then, AIMD shares have increased by 10.5% and is now trading at $0.5040. View the best growth stocks for 2025 here. How were Ainos' earnings last quarter? Ainos, Inc. (NASDAQ:AIMD) issued its quarterly earnings results on Monday, May, 12th. The company reported ($0.21) earnings per share (EPS) for the quarter. The company had revenue of $0.11 million for the quarter. When did Ainos' stock split? Ainos's stock reverse split on Thursday, December 14th 2023. The 1-5 reverse split was announced on Thursday, December 14th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. When did Ainos IPO? Ainos (AIMD) raised $3 million in an initial public offering on Tuesday, August 9th 2022. The company issued 800,000 shares at a price of $4.25 per share. Maxim Group served as the underwriter for the IPO and Brookline Capital Markets was co-manager. How do I buy shares of Ainos? Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Ainos own? Based on aggregate information from My MarketBeat watchlists, some other companies that Ainos investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE). Company Calendar Last Earnings5/12/2025Today6/13/2025Next Earnings (Estimated)8/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:AIMD Previous SymbolNASDAQ:AIMD CIK1014763 Webwww.ainos.com Phone858-869-2986Fax806-376-9301Employees40Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$13.77 million Net MarginsN/A Pretax Margin-39,441.14% Return on Equity-75.16% Return on Assets-50.22% Debt Debt-to-Equity Ratio0.50 Current Ratio1.37 Quick Ratio1.33 Sales & Book Value Annual Sales$106.21 thousand Price / Sales98.53 Cash FlowN/A Price / Cash FlowN/A Book Value$5.23 per share Price / Book0.10Miscellaneous Outstanding Shares20,764,000Free Float12,622,000Market Cap$10.47 million OptionableNot Optionable Beta2.20 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:AIMD) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ainos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.